Understanding EEF1A2. Advancing Research. Creating Hope.

Where the evidence actually stands

This site is built on a simple rule: a reader should always be able to tell the difference between something that has been measured and something that has been reasoned.

Pathogenic variants in EEF1A2 cause a severe neurodevelopmental disorder. That much is well established, and the gene–disease relationship is recorded in standard clinical databases. Beyond that, a great deal is genuinely unresolved — including the question that matters most for choosing any research direction at all.

The central unresolved question

Two readings of the same gene coexist in the current literature, and they point in opposite directions.

The largest functional cohort study argues that pathogenic variants act through loss of function: no heterozygous loss-of-function variants have been reported in affected individuals, the gene is highly intolerant to such variation, heterozygous null mice are normal, and expressing variant protein alongside wild type did not impair growth in yeast — which the authors took as evidence against a dominant-negative effect.

Mouse work points the other way. Mice homozygous for the D252H substitution are consistently more severely affected than mice with no eEF1A2 at all. A null allele is the floor of losing a protein's function; something worse than the floor implies the mutant protein is doing additional harm. The same argument is made from the mutational spectrum itself: more than fifty causative missense variants are known and no clear loss-of-function variants, which is an unusual profile.

And a reason not to generalise across the gene

The knock-in mouse for the most common variant, E122K, found the same mutant protein relatively stable in neurons yet highly unstable in skeletal myocytes, which led those authors to attribute the homozygous phenotype to loss of function in muscle rather than in brain. If one variant behaves differently in two tissues of one animal, conclusions do not travel freely from one variant to another, from animal to human, or from a cell line to a neuron.

A practical consequence for anyone planning experiments: most cultured cells — transformed, immortalised, iPSC-derived and primary alike — express the paralogue eEF1A1 either exclusively or alongside eEF1A2, which confounds functional work on this gene.